Cephalon Revises Fentora Labeling To Highlight Patient Selection Criteria Following Deaths
This article was originally published in The Pink Sheet Daily
Executive Summary
Among the deaths associated with the breakthrough cancer pain treatment were two patients prescribed the drug for migraines, Cephalon tells “The Pink Sheet” DAILY.